The announcement stated up to AU$4M revenues from the program.
You’re suggesting this will all be earned in November and December, where one month has already started and the other is shortened by holidays?
As they’re referring to quarters I expect it will run into 2022 and is hopefully extended.
They quoted the customers market cap as ~AU$200B.
Pfizer is more than this, so I’m assuming it’s AstraZeneca US$145B.
Ann: MedAdvisor signs $USD3m digital COVID-19 patient program, page-10
Add to My Watchlist
What is My Watchlist?
